Monogram Orthopaedics (NASDAQ:MGRM) Issues Earnings Results, Beats Expectations By $0.03 EPS

Monogram Orthopaedics (NASDAQ:MGRM) released its quarterly earnings results on Wednesday. The company reported ($0.08) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.11) by $0.03, Zacks reports.

Monogram Orthopaedics Price Performance

NASDAQ MGRM opened at $2.32 on Thursday. Monogram Orthopaedics has a 12 month low of $1.53 and a 12 month high of $4.90. The company has a market capitalization of $79.60 million, a price-to-earnings ratio of -4.94 and a beta of 1.66. The company’s fifty day moving average price is $2.54 and its two-hundred day moving average price is $2.50.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on MGRM. Roth Mkm began coverage on shares of Monogram Orthopaedics in a report on Monday, December 9th. They set a “buy” rating and a $4.00 price target for the company. Roth Capital raised shares of Monogram Orthopaedics to a “strong-buy” rating in a report on Monday, December 9th.

About Monogram Orthopaedics

Monogram Orthopaedics, Inc focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures.